Blueberries Medical Corp. (CSE: BBM)
Canada
· Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
Nov 18, 2024, 4:00 PM EST
Blueberries Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Revenue | 0.29 | 0.29 | 0.24 | 0.14 | 0.07 | - | Upgrade
|
Revenue Growth (YoY) | -6.12% | 22.44% | 69.70% | 110.29% | - | - | Upgrade
|
Cost of Revenue | 0.19 | 0.2 | 0.25 | 0.38 | 0 | - | Upgrade
|
Gross Profit | 0.1 | 0.08 | -0.02 | -0.25 | 0.06 | - | Upgrade
|
Selling, General & Admin | 1.14 | 1.29 | 1.36 | 0.67 | 2.55 | 5.49 | Upgrade
|
Operating Expenses | 1.35 | 1.46 | 1.62 | 1.54 | 4.19 | 6.8 | Upgrade
|
Operating Income | -1.25 | -1.38 | -1.64 | -1.79 | -4.12 | -6.8 | Upgrade
|
Interest Expense | -0.02 | -0.26 | -0.36 | -0.27 | -0.12 | - | Upgrade
|
Currency Exchange Gain (Loss) | 0.1 | 0.15 | -0.12 | -0.17 | -0.04 | 0.01 | Upgrade
|
Other Non Operating Income (Expenses) | 0.05 | 0.02 | 0.51 | 0.38 | -0.65 | -0 | Upgrade
|
EBT Excluding Unusual Items | -1.12 | -1.47 | -1.61 | -1.84 | -4.94 | -6.79 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -0.57 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.02 | - | - | - | Upgrade
|
Asset Writedown | -0.18 | -0.18 | - | -2.82 | - | - | Upgrade
|
Other Unusual Items | - | - | 0.13 | 0.09 | - | -4 | Upgrade
|
Pretax Income | -1.29 | -1.64 | -1.47 | -5.15 | -4.94 | -10.79 | Upgrade
|
Net Income | -1.29 | -1.64 | -1.47 | -5.15 | -4.94 | -10.79 | Upgrade
|
Net Income to Common | -1.29 | -1.64 | -1.47 | -5.15 | -4.94 | -10.79 | Upgrade
|
Shares Outstanding (Basic) | 310 | 219 | 169 | 149 | 124 | 109 | Upgrade
|
Shares Outstanding (Diluted) | 310 | 219 | 169 | 149 | 124 | 109 | Upgrade
|
Shares Change (YoY) | 57.88% | 29.85% | 13.73% | 19.83% | 13.78% | 126.63% | Upgrade
|
EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.03 | -0.04 | -0.10 | Upgrade
|
EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.03 | -0.04 | -0.10 | Upgrade
|
Free Cash Flow | -0.74 | -1.35 | -1.47 | -1.69 | -3.22 | -8.82 | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 | -0.08 | Upgrade
|
Gross Margin | 35.35% | 29.22% | -7.53% | -176.91% | 94.58% | - | Upgrade
|
Operating Margin | -432.61% | -477.44% | -696.79% | -1289.55% | -6251.54% | - | Upgrade
|
Profit Margin | -446.76% | -567.30% | -623.44% | -3709.64% | -7487.51% | - | Upgrade
|
Free Cash Flow Margin | -258.14% | -470.01% | -623.72% | -1217.90% | -4883.96% | - | Upgrade
|
EBITDA | -1.06 | -1.23 | -1.35 | -1.08 | -3.57 | -6.53 | Upgrade
|
D&A For EBITDA | 0.18 | 0.15 | 0.29 | 0.7 | 0.55 | 0.27 | Upgrade
|
EBIT | -1.25 | -1.38 | -1.64 | -1.79 | -4.12 | -6.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.